Related Experiment Video
Updated: Aug 8, 2026
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
[Analysis of the different proteomes between the acute leukemia cells and normal white blood cells]
Jiu-Wei Cui1, Guan-Jun Wang, Wei Li
1Department of Hematology and Onocology, The First Clinical Hospital Affliated to Jilin University, Changchun 130021, China.
Insights
Proteomic analysis reveals key protein expression differences in acute leukemia (AL) cells compared to normal white blood cells. This study enhances understanding of leukemogenesis and may aid in AL diagnosis.
Area of Science:
- Proteomics
- Molecular biology
- Hematology
Background:
- Acute leukemia (AL) is a complex hematological malignancy.
- Understanding the molecular mechanisms of leukemogenesis is crucial for diagnosis and treatment.
- Proteomic analysis offers a powerful approach to identify disease-specific protein expression patterns.
Purpose of the Study:
- To compare the proteomes of human acute leukemia (AL) cells and normal white blood cells.
- To identify differentially expressed proteins in AL for diagnostic and mechanistic insights.
- To elucidate the role of specific proteins in leukemogenesis.
Main Methods:
- Proteomic analysis of AL cells from 40 patients and normal cells from 20 volunteers.
- Two-dimensional electrophoresis (2-DE) for protein separation.
- Matrix assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) and electronspray ionization (ESI)-MS/MS for protein identification.
Main Results:
- Identification of differentially expressed proteins between AL cells and normal cells.
- Up-regulation of proteins involved in malignant transformation (e.g., Op18, NM23-H1), cell proliferation (e.g., PCNA), and apoptosis inhibition in AL cells.
- Down-regulation of proteins crucial for differentiation and physiological functions in AL cells.
Conclusions:
- Leukemogenesis involves complex molecular events with altered protein expression.
- Specific up-regulated proteins in AL cells are linked to malignant transformation, proliferation, and apoptosis inhibition.
- Proteome analysis provides a novel avenue for understanding AL pathogenesis and developing diagnostic tools.
Abstract:
This study was aimed to analyze the different proteomes between human acute leukemia (AL) cells and normal white blood cells by proteomic technology in order to lay the basis for diagnosing AL and understanding the mechanism of leukemogenesis. The proteins from AL cells of 40 AL patients identified by FAB classification and proteins from normal lymphocytes and granulocytes of 20 normal volunteers were separated by two-dimensional electrophoresis (2-DE), and the differentially expressed proteins between the two groups were identified by both matrix assisted laser desorption/ionization-time of flight-mass spectrometry (MALDI-TOF-MS) and electronspray ionization (ESI)-MS/MS. The results showed that among the differentially expressed proteins between AL cells and normal lymphocytes and granulocytes, some proteins involved in the process of malignant transformation (such as Op18, NM23-H1), cell proliferation (such as PCNA) and apoptosis inhibition (such as tumor necrosis factor inhibitor protein) were found to be up regulated in AL cells. However, some proteins involved in differentiation and physiological functions of normal cells were down regulated in AL cells. It is concluded that there are many events involved in the process of leukemogenesis, expression of some proteins relating to the malignant transformation, cell proliferation and apoptosis inhibition are up-regulated in AL cells. The proteome analysis may provide a new approach to explaining the molecular mechanism underlying the pathogenesis of AL.
